The FDA granted de novo authorization to the first artificial intelligence (AI) program to support breast cancer risk ...

Shares of Tempus AI, Inc. (TEM) jumped 17% on Monday morning after the company announced a new liquid biopsy assay intended ...

A new artificial intelligence (AI) test can identify which men with prostate cancer will benefit most from the life-extending ...

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced the launch of a new ...

Johnson & Johnson (NYSE:JNJ) recently announced promising Phase 1 study results for Pasritamig, a novel antibody for advanced ...

In the past, most targeted drug development efforts relied on single biomarkers, but cancer is far more complex. BostonGene’s ...

qXR-LN is an FDA-cleared solution to assist physicians with early nodule detection. Studies have shown that AI is highly ...

Although still in its infancy, this technology has already shown remarkable effectiveness in detecting and treating cancer, ...

EVP, Chief Medical Officer and Chief Product Officer, SOPHiA GENETICS | Embrace the transformative power of multimodal ...

AI could eliminate the "postcode lottery" surrounding a life-extending treatment for advanced prostate cancer, researchers ...

With lung cancer rates among non-smokers rising, especially young East Asian women, a new study released Monday is touting ...

FaceAge aims to predict biological age using AI, and links facial appearance with survival rates in cancer patients.